Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01965730 · ClinicalTrials.gov registry record · Early Phase 1
Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery
A Early Phase 1 study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT01965730: Clinical Trial Early Phase 1 study, sponsored by University of Pennsylvania.
NCT01965730 is a Early Phase 1 study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 8 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01965730, a Early Phase 1 study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study hopes to determine the optimal antifibrinolytic dosing to decrease bleeding and blood transfusion after cardiac surgery without increasing adverse events
Primary Outcome
The primary objective of the study will be to determine if a change in EACA dosing for cardiac surgery cases involving circulatory arrest actually leads to a quantifiable change in the degree of fibrinolysis as measured by TEG.
Interventions
- DRUG epsilon-aminocaproic acid (EACA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-06 |
| Phase | Early Phase 1 |
Why NCT01965730 stopped before completion
NCT01965730 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which epsilon-aminocaproic acid (EACA) is the first listed.
NCT01965730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01965730 about?
NCT01965730 is a clinical study titled "Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery". This study hopes to determine the optimal antifibrinolytic dosing to decrease bleeding and blood transfusion after cardiac surgery without increasing adverse events
What is the current status of trial NCT01965730?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2013-01. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01965730?
The interventions under investigation include: epsilon-aminocaproic acid (EACA) (DRUG).
Who is sponsoring clinical trial NCT01965730?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01965730's enrollment target sits among peer trials
8 1782nd of 2000 higher than 176 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia